scispace - formally typeset
G

Gadi Rennert

Researcher at Technion – Israel Institute of Technology

Publications -  20
Citations -  2064

Gadi Rennert is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Genome-wide association study & Breast cancer. The author has an hindex of 9, co-authored 20 publications receiving 1555 citations. Previous affiliations of Gadi Rennert include Clalit Health Services.

Papers
More filters
Journal ArticleDOI

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou, +396 more
- 02 Nov 2017 - 
TL;DR: A genome-wide association study of breast cancer in 122,977 cases and 105,974 controls of European ancestry and 14,068 cases and 13,104 controls of East Asian ancestry finds that heritability of Breast cancer due to all single-nucleotide polymorphisms in regulatory features was 2–5-fold enriched relative to the genome- wide average.
Journal ArticleDOI

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

Elizabeth Page, +150 more
- 01 Dec 2019 - 
TL;DR: After 3 yr of prostate-specific antigen (PSA) testing, it is demonstrated that after 3’yr of screening, more serious prostate cancers are detected in men with BRCA2 mutations than in those without these mutations.
Journal ArticleDOI

The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients

TL;DR: High incidence of gammopathy suggests an important role of the adaptive immune system in the development of GD, and adult patients with GD should be monitored for skeletal disease and cancers including multiple myeloma.
Journal ArticleDOI

HMG CoA reductase inhibitors and the risk of colorectal cancer

TL;DR: HMG CoA reductase inhibitors are associated with a 51% reduction in the risk of colorectal cancer, and the protective effect is specific to this class of lipid-lowering agents.